Drug Trial Radar · NCT07951736
Posterior Default Network Modulation in Alcohol Use Disorder
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Jan 2027
Primary completion
Jun 2031
Study completion Jun 2031
Sponsor
- Lead sponsor
- Indiana UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- First posted
- Nov 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This proposal will test whether repetitive transcranial magnetic stimulation (rTMS) modulation of the brain's posterior default mode network (pDMN) will alter alcohol craving, alcohol seeking and impulsivity in men and women who have an alcohol use disorder but are not seeking treatment.
Conditions
- Alcohol Use Disorder
Interventions
Continuous theta burst stimulation (cTBS)Other
cTBS consists of a continuous train of 3-pulse bursts of neurostimulation.
Intermittent theta burst stimulation (iTBS)Other
iTBS consists of 2 second trains of 3-pulse bursts of neurostimulation, alternating with 8 seconds of rest.
Sham TBSOther
Sham TBS duplicates the peripheral sensations of TBS without neurostimulation
IV alcohol solutionDrug
Sterile alcohol is mixed with USP saline to a concentration of 6%
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in pDMN BOLD responses to alcohol taste after iTBS, cTBS or sham treatment.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
- Change in cue-induced craving after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
- Change in the number of completed trials and alcohol infusions earned on a progressive ratio task after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
- Change in impulsivity assessed using a delay discounting task after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
- Change in pDMN BOLD responses during a delay discounting task after TBS.Time frame: 3 single day laboratory sessions scheduled 7-14 days apart
Locations
1 site in 1 country. Site status is shown where the registry gives one.
IU Health University Hospital
Indianapolis, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.